- Home
- SMTI
SMTI
Sanara MedTech Inc.
as of 12-05-2025 4:00pm EST
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | FORT WORTH |
| Market Cap: | 186.9M | IPO Year: | N/A |
| Target Price: | $41.00 | AVG Volume (30 days): | 69.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.90 - $38.68 | Next Earning Date: | 11-12-2025 |
| Revenue: | $101,877,532 | Revenue Growth: | 30.52% |
| Revenue Growth (this year): | 21.6% | Revenue Growth (next year): | 16.70% |
AI-Powered SMTI Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare SMTI vs Leading Stocks
See how SMTI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SMTI Sanara MedTech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.